Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
177Lu-PSMA-617 for metastatic prostate cancer in India.
Ghose A, Banerjee S, Choudhury PS, Maniam A, Gupta M, Banna GL, Vasdev N, Ghose A, Noronha V, Mitra S. Ghose A, et al. Among authors: choudhury ps. Lancet Reg Health Southeast Asia. 2024 Sep 12;30:100484. doi: 10.1016/j.lansea.2024.100484. eCollection 2024 Nov. Lancet Reg Health Southeast Asia. 2024. PMID: 39309758 Free PMC article. No abstract available.
Correction to: Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study.
Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Gupta M, et al. Among authors: choudhury ps. Nucl Med Mol Imaging. 2020 Oct;54(5):267. doi: 10.1007/s13139-020-00662-7. Epub 2020 Aug 17. Nucl Med Mol Imaging. 2020. PMID: 33088359 Free PMC article.
Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography.
Gupta M, Choudhury PS, Rawal S, Goel HC, Rao SA. Gupta M, et al. Among authors: choudhury ps. Urol Ann. 2019 Apr-Jun;11(2):155-162. doi: 10.4103/UA.UA_111_18. Urol Ann. 2019. PMID: 31040600 Free PMC article.
40 results